Validation of recombinant Sendai virus in a non-natural host model.
about
Cystic Fibrosis Gene Therapy in the UK and Elsewhere.Efficient gene delivery to pig airway epithelia and submucosal glands using helper-dependent adenoviral vectorsPreparation for a first-in-man lentivirus trial in patients with cystic fibrosis.Expert opinion in biological therapy: update on developments in lung gene transfer.Enhancement of lung gene delivery after aerosol: a new strategy using non-viral complexes with antibacterial properties.
P2860
Validation of recombinant Sendai virus in a non-natural host model.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Validation of recombinant Sendai virus in a non-natural host model.
@en
Validation of recombinant Sendai virus in a non-natural host model.
@nl
type
label
Validation of recombinant Sendai virus in a non-natural host model.
@en
Validation of recombinant Sendai virus in a non-natural host model.
@nl
prefLabel
Validation of recombinant Sendai virus in a non-natural host model.
@en
Validation of recombinant Sendai virus in a non-natural host model.
@nl
P2093
P2860
P356
P1433
P1476
Validation of recombinant Sendai virus in a non-natural host model
@en
P2093
E W F W Alton
L Somerton
M Hasegawa
P2860
P2888
P304
P356
10.1038/GT.2010.131
P577
2010-10-21T00:00:00Z
P5875
P6179
1033291100